These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3816985)

  • 1. 5HT2 binding sites after mianserin: comparison of loss of sites and brain levels of drug.
    Sanders-Bush E; Breeding M; Roznoski M
    Eur J Pharmacol; 1987 Jan; 133(2):199-204. PubMed ID: 3816985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior.
    Smith RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1990 Aug; 254(2):484-8. PubMed ID: 2166792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites.
    Gandolfi O; Barbaccia ML; Costa E
    Life Sci; 1985 Feb; 36(8):713-21. PubMed ID: 2983168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol.
    Alexander BS; Wood MD
    J Pharm Pharmacol; 1987 Aug; 39(8):664-6. PubMed ID: 2888864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective interaction of mianserin with 5-HT3 receptors.
    Wood MD; Thomas DR; Watkins CJ; Newberry NR
    J Pharm Pharmacol; 1993 Aug; 45(8):711-4. PubMed ID: 7901368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of methiothepin on imipramine- or mianserin- induced subsensitivity of serotonergic receptors.
    Segawa T; Uehara M
    Life Sci; 1982 Mar; 30(10):809-12. PubMed ID: 7070196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the affinity for [3H]mianserin-labelled receptors in brain and antagonism of the serotonin pressor response in pithed rats.
    Kalkman HO; Batink HD; Thoolen MJ; Timmermans PB; van Zwieten PA
    Biochem Pharmacol; 1983 Jul; 32(13):2111-3. PubMed ID: 6870938
    [No Abstract]   [Full Text] [Related]  

  • 8. On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of beta-adrenergic receptors.
    Barbaccia ML; Brunello N; Chuang DM; Costa E
    Neuropharmacology; 1983 Mar; 22(3 Spec No):373-83. PubMed ID: 6304555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of 5HT1C and/or 5HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal.
    Lal H; Prather PL; Rezazadeh SM
    Alcohol Clin Exp Res; 1993 Apr; 17(2):411-7. PubMed ID: 8488986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the regulatory adaptation of the 5HT recognition sites labelled by 3H-mianserin or 3H-ketanserin.
    Barbaccia ML; Gandolfi O; Chuang DM; Costa E
    Neuropharmacology; 1983 Jan; 22(1):123-6. PubMed ID: 6843781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors.
    Gandolfi O; Barbaccia ML; Costa E
    J Pharmacol Exp Ther; 1984 Jun; 229(3):782-6. PubMed ID: 6327970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mianserin-induced down-regulation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors stably expressed in the human neuroblastoma cell line SH-SY5Y.
    Newton RA; Elliott JM
    J Neurochem; 1997 Sep; 69(3):1031-8. PubMed ID: 9282925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
    Ge J; Barnes JM; Towers P; Barnes NM
    Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive changes in the 5-HT2 binding site after chronic administration of agonists and antagonists.
    Blackshear MA; Martin LL; Sanders-Bush E
    Neuropharmacology; 1986 Nov; 25(11):1267-71. PubMed ID: 3796800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
    Barker EL; Sanders-Bush E
    Mol Pharmacol; 1993 Oct; 44(4):725-30. PubMed ID: 8232222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin receptor sensitivity after acute and chronic treatment with mianserin.
    Blackshear MA; Sanders-Bush E
    J Pharmacol Exp Ther; 1982 May; 221(2):303-8. PubMed ID: 7077527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3H-Mianserin binding in calf caudate: possible involvement of serotonin receptors in anti-depressant drug action.
    Whitaker PM; Cross AJ
    Biochem Pharmacol; 1980 Oct; 29(19):2709-12. PubMed ID: 6107087
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in the rat brain 5-HT1A and 5-HT2 receptors after chronic administration of levoprotiline, (+)-oxaprotiline and other antidepressant drugs.
    Klimek V; Zak-Knapik J; Cannizzaro C
    Pol J Pharmacol Pharm; 1992; 44(6):549-60. PubMed ID: 1305956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
    Gobbi M; Parotti L; Mennini T
    Mol Pharmacol; 1996 Mar; 49(3):556-9. PubMed ID: 8643096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.